Top Markets
#1 MON MON +2,760.08%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.36%
#4 eCash eCash +37.30%
#5 Siren Siren +24.28%
#6 Collector Crypt Collector Crypt +23.96%
#7 PinGo PinGo +23.93%
#8 SAFEcoin SAFEcoin +19.72%
#9 Janction Janction +19.66%
#10 Beldex Beldex +15.26%
Coin of the day
MON MON
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rankning i aktier #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Aktiekurs
$0.30840035
Marknadsvärde
$94.37M
Förändring (1 dag)
0.00%
Förändring (1 år)
-34.60%
Land
FR
Handel Sensorion SA (ALSEN)

Kategori

Healthcare
Antal utestående aktier för Sensorion SA (ALSEN)
Antal utestående aktier per December 2025: 300.92M
Enligt de senaste finansiella rapporterna och aktiekursen för Sensorion SA är det aktuella antalet utestående aktier 300.92M. I slutet av December 2023 hade företaget 133.42M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Sensorion SA (ALSEN) från 2011 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 300.92M 5.97%
2024 283.97M 112.83%
2023 133.42M 67.12%
2022 79.84M 0.18%
2021 79.69M 31.16%
2020 60.76M 225.81%
2019 18.65M 63.39%
2018 11.41M 58.34%
2017 7.21M 5.84%
2016 6.81M 59.47%
2015 4.27M 30.90%
2014 3.26M 0.00%
2013 3.26M 0.00%
2012 3.26M 0.00%
2011 3.26M 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 1,376.33%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M -15.56%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M -65.44%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M -36.86%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -79.59%
NL